# Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients

> **NCT02935595** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 9 (actual)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT02935595
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-14
- **Primary completion:** 2017-08-16
- **Final completion:** 2017-08-16
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02935595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02935595, "Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02935595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*